nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyltestosterone—Prednisone—multiple sclerosis	0.154	0.506	CrCtD
Methyltestosterone—Prednisolone—multiple sclerosis	0.151	0.494	CrCtD
Methyltestosterone—breast cancer—Dexamethasone—multiple sclerosis	0.115	0.5	CpDpCtD
Methyltestosterone—breast cancer—Betamethasone—multiple sclerosis	0.115	0.5	CpDpCtD
Methyltestosterone—ALB—multiple sclerosis	0.0691	1	CbGaD
Methyltestosterone—CYP19A1—Betamethasone—multiple sclerosis	0.0223	0.16	CbGbCtD
Methyltestosterone—SLCO1A2—Prednisolone—multiple sclerosis	0.0172	0.123	CbGbCtD
Methyltestosterone—SLCO1A2—Prednisone—multiple sclerosis	0.0162	0.116	CbGbCtD
Methyltestosterone—CYP19A1—Dexamethasone—multiple sclerosis	0.0129	0.0929	CbGbCtD
Methyltestosterone—SLCO1A2—Dexamethasone—multiple sclerosis	0.0101	0.0727	CbGbCtD
Methyltestosterone—ALB—Prednisone—multiple sclerosis	0.00838	0.0602	CbGbCtD
Methyltestosterone—SLCO1A2—Methotrexate—multiple sclerosis	0.00814	0.0584	CbGbCtD
Methyltestosterone—SLC22A8—Methotrexate—multiple sclerosis	0.00709	0.0509	CbGbCtD
Methyltestosterone—CYP3A4—Fingolimod—multiple sclerosis	0.00673	0.0483	CbGbCtD
Methyltestosterone—Potassium Canrenoate—Prednisone—multiple sclerosis	0.00651	0.0288	CrCrCtD
Methyltestosterone—Potassium Canrenoate—Prednisolone—multiple sclerosis	0.00635	0.0281	CrCrCtD
Methyltestosterone—Medrysone—Methylprednisolone—multiple sclerosis	0.00602	0.0266	CrCrCtD
Methyltestosterone—Medroxyprogesterone Acetate—Methylprednisolone—multiple sclerosis	0.0058	0.0257	CrCrCtD
Methyltestosterone—Danazol—Prednisone—multiple sclerosis	0.0055	0.0243	CrCrCtD
Methyltestosterone—Medrysone—Prednisolone—multiple sclerosis	0.00536	0.0237	CrCrCtD
Methyltestosterone—CYP2B6—Dexamethasone—multiple sclerosis	0.00534	0.0383	CbGbCtD
Methyltestosterone—Hydrocortamate—Methylprednisolone—multiple sclerosis	0.00524	0.0232	CrCrCtD
Methyltestosterone—Cortisone acetate—Methylprednisolone—multiple sclerosis	0.00508	0.0224	CrCrCtD
Methyltestosterone—Testolactone—Methylprednisolone—multiple sclerosis	0.00493	0.0218	CrCrCtD
Methyltestosterone—Testolactone—Dexamethasone—multiple sclerosis	0.00485	0.0214	CrCrCtD
Methyltestosterone—Testolactone—Betamethasone—multiple sclerosis	0.00485	0.0214	CrCrCtD
Methyltestosterone—Hydrocortamate—Prednisone—multiple sclerosis	0.00478	0.0211	CrCrCtD
Methyltestosterone—Testolactone—Triamcinolone—multiple sclerosis	0.00474	0.0209	CrCrCtD
Methyltestosterone—Hydrocortamate—Prednisolone—multiple sclerosis	0.00467	0.0206	CrCrCtD
Methyltestosterone—Cortisone acetate—Prednisone—multiple sclerosis	0.00463	0.0205	CrCrCtD
Methyltestosterone—Cortisone acetate—Prednisolone—multiple sclerosis	0.00452	0.02	CrCrCtD
Methyltestosterone—Testolactone—Prednisone—multiple sclerosis	0.00449	0.0199	CrCrCtD
Methyltestosterone—Fluoxymesterone—Betamethasone—multiple sclerosis	0.00446	0.0197	CrCrCtD
Methyltestosterone—Fluoxymesterone—Dexamethasone—multiple sclerosis	0.00446	0.0197	CrCrCtD
Methyltestosterone—Prednisone—Methylprednisolone—multiple sclerosis	0.00441	0.0195	CrCrCtD
Methyltestosterone—Fludrocortisone—Methylprednisolone—multiple sclerosis	0.00441	0.0195	CrCrCtD
Methyltestosterone—Testolactone—Prednisolone—multiple sclerosis	0.00439	0.0194	CrCrCtD
Methyltestosterone—Fluoxymesterone—Triamcinolone—multiple sclerosis	0.00435	0.0192	CrCrCtD
Methyltestosterone—Prednisone—Betamethasone—multiple sclerosis	0.00434	0.0192	CrCrCtD
Methyltestosterone—Prednisone—Dexamethasone—multiple sclerosis	0.00434	0.0192	CrCrCtD
Methyltestosterone—Fludrocortisone—Dexamethasone—multiple sclerosis	0.00434	0.0192	CrCrCtD
Methyltestosterone—Fludrocortisone—Betamethasone—multiple sclerosis	0.00434	0.0192	CrCrCtD
Methyltestosterone—CYP3A4—Methylprednisolone—multiple sclerosis	0.00434	0.0311	CbGbCtD
Methyltestosterone—Fludrocortisone—Triamcinolone—multiple sclerosis	0.00424	0.0188	CrCrCtD
Methyltestosterone—Prednisone—Triamcinolone—multiple sclerosis	0.00424	0.0188	CrCrCtD
Methyltestosterone—ALB—Methotrexate—multiple sclerosis	0.00421	0.0302	CbGbCtD
Methyltestosterone—Loteprednol—Methylprednisolone—multiple sclerosis	0.0041	0.0181	CrCrCtD
Methyltestosterone—Fluoxymesterone—Prednisolone—multiple sclerosis	0.00403	0.0178	CrCrCtD
Methyltestosterone—Loteprednol—Betamethasone—multiple sclerosis	0.00403	0.0178	CrCrCtD
Methyltestosterone—Loteprednol—Dexamethasone—multiple sclerosis	0.00403	0.0178	CrCrCtD
Methyltestosterone—Fludrocortisone—Prednisone—multiple sclerosis	0.00402	0.0178	CrCrCtD
Methyltestosterone—Loteprednol—Triamcinolone—multiple sclerosis	0.00394	0.0174	CrCrCtD
Methyltestosterone—Fludrocortisone—Prednisolone—multiple sclerosis	0.00393	0.0174	CrCrCtD
Methyltestosterone—Progesterone—Prednisolone—multiple sclerosis	0.00393	0.0174	CrCrCtD
Methyltestosterone—Prednisone—Prednisolone—multiple sclerosis	0.00393	0.0174	CrCrCtD
Methyltestosterone—Prednisolone—Methylprednisolone—multiple sclerosis	0.00375	0.0166	CrCrCtD
Methyltestosterone—Loteprednol—Prednisone—multiple sclerosis	0.00374	0.0165	CrCrCtD
Methyltestosterone—Prednisolone—Betamethasone—multiple sclerosis	0.00369	0.0163	CrCrCtD
Methyltestosterone—Prednisolone—Dexamethasone—multiple sclerosis	0.00369	0.0163	CrCrCtD
Methyltestosterone—Loteprednol—Prednisolone—multiple sclerosis	0.00365	0.0161	CrCrCtD
Methyltestosterone—Prednisolone—Triamcinolone—multiple sclerosis	0.0036	0.0159	CrCrCtD
Methyltestosterone—Hydrocortisone—Methylprednisolone—multiple sclerosis	0.0036	0.0159	CrCrCtD
Methyltestosterone—Hydrocortisone—Betamethasone—multiple sclerosis	0.00354	0.0157	CrCrCtD
Methyltestosterone—Hydrocortisone—Dexamethasone—multiple sclerosis	0.00354	0.0157	CrCrCtD
Methyltestosterone—Hydrocortisone—Triamcinolone—multiple sclerosis	0.00346	0.0153	CrCrCtD
Methyltestosterone—Prednisolone—Prednisone—multiple sclerosis	0.00342	0.0151	CrCrCtD
Methyltestosterone—Testosterone—Prednisolone—multiple sclerosis	0.00341	0.0151	CrCrCtD
Methyltestosterone—CYP3A4—Triamcinolone—multiple sclerosis	0.00329	0.0236	CbGbCtD
Methyltestosterone—Hydrocortisone—Prednisone—multiple sclerosis	0.00328	0.0145	CrCrCtD
Methyltestosterone—Hydrocortisone—Prednisolone—multiple sclerosis	0.0032	0.0142	CrCrCtD
Methyltestosterone—CYP3A4—Mitoxantrone—multiple sclerosis	0.00316	0.0227	CbGbCtD
Methyltestosterone—CYP3A4—Betamethasone—multiple sclerosis	0.00282	0.0202	CbGbCtD
Methyltestosterone—CYP3A4—Prednisolone—multiple sclerosis	0.00278	0.02	CbGbCtD
Methyltestosterone—Peliosis hepatis—Azathioprine—multiple sclerosis	0.00274	0.127	CcSEcCtD
Methyltestosterone—CYP3A4—Prednisone—multiple sclerosis	0.00263	0.0189	CbGbCtD
Methyltestosterone—CYP3A4—Dexamethasone—multiple sclerosis	0.00164	0.0118	CbGbCtD
Methyltestosterone—Polycythaemia—Prednisone—multiple sclerosis	0.00076	0.035	CcSEcCtD
Methyltestosterone—Oligospermia—Methotrexate—multiple sclerosis	0.000661	0.0305	CcSEcCtD
Methyltestosterone—Azoospermia—Methotrexate—multiple sclerosis	0.000515	0.0237	CcSEcCtD
Methyltestosterone—Embolism venous—Prednisolone—multiple sclerosis	0.000452	0.0209	CcSEcCtD
Methyltestosterone—Embolism venous—Triamcinolone—multiple sclerosis	0.000416	0.0192	CcSEcCtD
Methyltestosterone—Embolism venous—Methylprednisolone—multiple sclerosis	0.000415	0.0191	CcSEcCtD
Methyltestosterone—Menstruation irregular—Prednisolone—multiple sclerosis	0.000412	0.019	CcSEcCtD
Methyltestosterone—Hirsutism—Prednisolone—multiple sclerosis	0.000393	0.0181	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Azathioprine—multiple sclerosis	0.000392	0.0181	CcSEcCtD
Methyltestosterone—Menstruation irregular—Triamcinolone—multiple sclerosis	0.000379	0.0175	CcSEcCtD
Methyltestosterone—Menstruation irregular—Methylprednisolone—multiple sclerosis	0.000378	0.0174	CcSEcCtD
Methyltestosterone—Embolism venous—Dexamethasone—multiple sclerosis	0.000377	0.0174	CcSEcCtD
Methyltestosterone—Embolism venous—Betamethasone—multiple sclerosis	0.000377	0.0174	CcSEcCtD
Methyltestosterone—Hirsutism—Triamcinolone—multiple sclerosis	0.000361	0.0167	CcSEcCtD
Methyltestosterone—Hirsutism—Methylprednisolone—multiple sclerosis	0.00036	0.0166	CcSEcCtD
Methyltestosterone—Menstruation irregular—Dexamethasone—multiple sclerosis	0.000344	0.0159	CcSEcCtD
Methyltestosterone—Menstruation irregular—Betamethasone—multiple sclerosis	0.000344	0.0159	CcSEcCtD
Methyltestosterone—Angiopathy—Fingolimod—multiple sclerosis	0.00034	0.0157	CcSEcCtD
Methyltestosterone—Alopecia—Fingolimod—multiple sclerosis	0.000331	0.0153	CcSEcCtD
Methyltestosterone—Embolism venous—Prednisone—multiple sclerosis	0.000329	0.0152	CcSEcCtD
Methyltestosterone—Hirsutism—Dexamethasone—multiple sclerosis	0.000328	0.0151	CcSEcCtD
Methyltestosterone—Hirsutism—Betamethasone—multiple sclerosis	0.000328	0.0151	CcSEcCtD
Methyltestosterone—Amenorrhoea—Mitoxantrone—multiple sclerosis	0.000317	0.0146	CcSEcCtD
Methyltestosterone—Menstruation irregular—Prednisone—multiple sclerosis	0.0003	0.0138	CcSEcCtD
Methyltestosterone—Hirsutism—Prednisone—multiple sclerosis	0.000285	0.0132	CcSEcCtD
Methyltestosterone—Paraesthesia—Fingolimod—multiple sclerosis	0.000239	0.011	CcSEcCtD
Methyltestosterone—Amenorrhoea—Methylprednisolone—multiple sclerosis	0.000238	0.011	CcSEcCtD
Methyltestosterone—Dydrogesterone—PGR—multiple sclerosis	0.000238	0.146	CrCbGaD
Methyltestosterone—Amenorrhoea—Dexamethasone—multiple sclerosis	0.000217	0.01	CcSEcCtD
Methyltestosterone—Amenorrhoea—Betamethasone—multiple sclerosis	0.000217	0.01	CcSEcCtD
Methyltestosterone—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.000215	0.0293	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.000215	0.0293	CbGpPWpGaD
Methyltestosterone—Haemoglobin—Cladribine—multiple sclerosis	0.000214	0.00985	CcSEcCtD
Methyltestosterone—Haemorrhage—Cladribine—multiple sclerosis	0.000213	0.0098	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.000209	0.00962	CcSEcCtD
Methyltestosterone—Angiopathy—Cladribine—multiple sclerosis	0.000193	0.0089	CcSEcCtD
Methyltestosterone—Amenorrhoea—Prednisone—multiple sclerosis	0.000189	0.00871	CcSEcCtD
Methyltestosterone—Alopecia—Cladribine—multiple sclerosis	0.000188	0.00866	CcSEcCtD
Methyltestosterone—Allylestrenol—PGR—multiple sclerosis	0.000185	0.113	CrCbGaD
Methyltestosterone—Haemoglobin—Azathioprine—multiple sclerosis	0.000174	0.00801	CcSEcCtD
Methyltestosterone—Haemorrhage—Azathioprine—multiple sclerosis	0.000173	0.00797	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.000171	0.0079	CcSEcCtD
Methyltestosterone—Headache—Fingolimod—multiple sclerosis	0.000167	0.0077	CcSEcCtD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—HNRNPA1—multiple sclerosis	0.000164	0.0224	CbGpPWpGaD
Methyltestosterone—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.000157	0.00726	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.000157	0.00725	CcSEcCtD
Methyltestosterone—Anxiety—Cladribine—multiple sclerosis	0.000157	0.00724	CcSEcCtD
Methyltestosterone—Alopecia—Azathioprine—multiple sclerosis	0.000153	0.00704	CcSEcCtD
Methyltestosterone—Danazol—CCL2—multiple sclerosis	0.000153	0.0935	CrCbGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000148	0.0201	CbGpPWpGaD
Methyltestosterone—Etonogestrel—PGR—multiple sclerosis	0.000144	0.0884	CrCbGaD
Methyltestosterone—Megestrol acetate—PGR—multiple sclerosis	0.000143	0.0878	CrCbGaD
Methyltestosterone—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.000143	0.00659	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.000143	0.00659	CcSEcCtD
Methyltestosterone—Haemoglobin—Mitoxantrone—multiple sclerosis	0.00014	0.00648	CcSEcCtD
Methyltestosterone—Haemorrhage—Mitoxantrone—multiple sclerosis	0.00014	0.00644	CcSEcCtD
Methyltestosterone—Paraesthesia—Cladribine—multiple sclerosis	0.000136	0.00625	CcSEcCtD
Methyltestosterone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000135	0.0184	CbGpPWpGaD
Methyltestosterone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000135	0.0184	CbGpPWpGaD
Methyltestosterone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000133	0.0182	CbGpPWpGaD
Methyltestosterone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000133	0.0182	CbGpPWpGaD
Methyltestosterone—CYP19A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000132	0.0179	CbGpPWpGaD
Methyltestosterone—CYP19A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000132	0.0179	CbGpPWpGaD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—ZMIZ1—multiple sclerosis	0.00013	0.0177	CbGpPWpGaD
Methyltestosterone—Drospirenone—PGR—multiple sclerosis	0.000125	0.0766	CrCbGaD
Methyltestosterone—Gynaecomastia—Methotrexate—multiple sclerosis	0.000124	0.00572	CcSEcCtD
Methyltestosterone—Alopecia—Mitoxantrone—multiple sclerosis	0.000123	0.00569	CcSEcCtD
Methyltestosterone—SLCO1A2—Transport of organic anions—ALB—multiple sclerosis	0.000118	0.016	CbGpPWpGaD
Methyltestosterone—Haemoglobin—Prednisolone—multiple sclerosis	0.000115	0.00531	CcSEcCtD
Methyltestosterone—Haemorrhage—Prednisolone—multiple sclerosis	0.000115	0.00529	CcSEcCtD
Methyltestosterone—CYP19A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000108	0.0147	CbGpPWpGaD
Methyltestosterone—CYP19A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000108	0.0147	CbGpPWpGaD
Methyltestosterone—SHBG—Nongenotropic Androgen signaling—MAPK1—multiple sclerosis	0.000108	0.0147	CbGpPWpGaD
Methyltestosterone—Haemoglobin—Triamcinolone—multiple sclerosis	0.000106	0.00489	CcSEcCtD
Methyltestosterone—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000106	0.00488	CcSEcCtD
Methyltestosterone—Haemorrhage—Triamcinolone—multiple sclerosis	0.000105	0.00486	CcSEcCtD
Methyltestosterone—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000105	0.00485	CcSEcCtD
Methyltestosterone—AR—Nuclear Receptors—PGR—multiple sclerosis	0.000105	0.0142	CbGpPWpGaD
Methyltestosterone—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000104	0.0048	CcSEcCtD
Methyltestosterone—CYP19A1—Ovarian Infertility Genes—PGR—multiple sclerosis	0.000103	0.0141	CbGpPWpGaD
Methyltestosterone—Anxiety—Mitoxantrone—multiple sclerosis	0.000103	0.00476	CcSEcCtD
Methyltestosterone—Levonorgestrel—PGR—multiple sclerosis	0.000102	0.0625	CrCbGaD
Methyltestosterone—Anaphylactic shock—Mitoxantrone—multiple sclerosis	9.93e-05	0.00458	CcSEcCtD
Methyltestosterone—Haemoglobin—Dexamethasone—multiple sclerosis	9.61e-05	0.00443	CcSEcCtD
Methyltestosterone—Haemoglobin—Betamethasone—multiple sclerosis	9.61e-05	0.00443	CcSEcCtD
Methyltestosterone—AR—Androgen receptor signaling pathway—ZMIZ1—multiple sclerosis	9.61e-05	0.0131	CbGpPWpGaD
Methyltestosterone—Haemorrhage—Betamethasone—multiple sclerosis	9.56e-05	0.00441	CcSEcCtD
Methyltestosterone—Haemorrhage—Dexamethasone—multiple sclerosis	9.56e-05	0.00441	CcSEcCtD
Methyltestosterone—Angiopathy—Methylprednisolone—multiple sclerosis	9.54e-05	0.0044	CcSEcCtD
Methyltestosterone—Headache—Cladribine—multiple sclerosis	9.46e-05	0.00436	CcSEcCtD
Methyltestosterone—Danazol—PGR—multiple sclerosis	9.29e-05	0.057	CrCbGaD
Methyltestosterone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	9.22e-05	0.0126	CbGpPWpGaD
Methyltestosterone—Nausea—Cladribine—multiple sclerosis	8.97e-05	0.00414	CcSEcCtD
Methyltestosterone—Paraesthesia—Mitoxantrone—multiple sclerosis	8.91e-05	0.00411	CcSEcCtD
Methyltestosterone—Spironolactone—PGR—multiple sclerosis	8.9e-05	0.0546	CrCbGaD
Methyltestosterone—SLCO1A2—Recycling of bile acids and salts—ALB—multiple sclerosis	8.71e-05	0.0119	CbGpPWpGaD
Methyltestosterone—Angiopathy—Dexamethasone—multiple sclerosis	8.68e-05	0.004	CcSEcCtD
Methyltestosterone—Angiopathy—Betamethasone—multiple sclerosis	8.68e-05	0.004	CcSEcCtD
Methyltestosterone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	8.56e-05	0.0117	CbGpPWpGaD
Methyltestosterone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	8.56e-05	0.0117	CbGpPWpGaD
Methyltestosterone—Drospirenone—BCHE—multiple sclerosis	8.56e-05	0.0525	CrCbGaD
Methyltestosterone—Alopecia—Betamethasone—multiple sclerosis	8.45e-05	0.0039	CcSEcCtD
Methyltestosterone—Alopecia—Dexamethasone—multiple sclerosis	8.45e-05	0.0039	CcSEcCtD
Methyltestosterone—CYP2B6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	8.45e-05	0.0115	CbGpPWpGaD
Methyltestosterone—CYP2B6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	8.45e-05	0.0115	CbGpPWpGaD
Methyltestosterone—CYP19A1—FSH signaling pathway—BDNF—multiple sclerosis	8.42e-05	0.0115	CbGpPWpGaD
Methyltestosterone—Haemoglobin—Prednisone—multiple sclerosis	8.37e-05	0.00386	CcSEcCtD
Methyltestosterone—Medroxyprogesterone Acetate—PGR—multiple sclerosis	8.34e-05	0.0511	CrCbGaD
Methyltestosterone—Haemorrhage—Prednisone—multiple sclerosis	8.33e-05	0.00384	CcSEcCtD
Methyltestosterone—Norethindrone—PGR—multiple sclerosis	8.26e-05	0.0507	CrCbGaD
Methyltestosterone—AR—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	8.26e-05	0.0113	CbGpPWpGaD
Methyltestosterone—Anaphylactic shock—Prednisolone—multiple sclerosis	8.14e-05	0.00376	CcSEcCtD
Methyltestosterone—Anxiety—Methylprednisolone—multiple sclerosis	7.77e-05	0.00358	CcSEcCtD
Methyltestosterone—Headache—Azathioprine—multiple sclerosis	7.69e-05	0.00355	CcSEcCtD
Methyltestosterone—Angiopathy—Prednisone—multiple sclerosis	7.56e-05	0.00349	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Triamcinolone—multiple sclerosis	7.49e-05	0.00345	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	7.47e-05	0.00345	CcSEcCtD
Methyltestosterone—Alopecia—Prednisone—multiple sclerosis	7.36e-05	0.00339	CcSEcCtD
Methyltestosterone—Paraesthesia—Prednisolone—multiple sclerosis	7.31e-05	0.00337	CcSEcCtD
Methyltestosterone—AR—Nuclear Receptors—VDR—multiple sclerosis	7.3e-05	0.00995	CbGpPWpGaD
Methyltestosterone—Nausea—Azathioprine—multiple sclerosis	7.29e-05	0.00336	CcSEcCtD
Methyltestosterone—CYP19A1—Ovarian Infertility Genes—VDR—multiple sclerosis	7.21e-05	0.00982	CbGpPWpGaD
Methyltestosterone—Anxiety—Betamethasone—multiple sclerosis	7.06e-05	0.00326	CcSEcCtD
Methyltestosterone—Anxiety—Dexamethasone—multiple sclerosis	7.06e-05	0.00326	CcSEcCtD
Methyltestosterone—Haemoglobin—Methotrexate—multiple sclerosis	7e-05	0.00323	CcSEcCtD
Methyltestosterone—Haemorrhage—Methotrexate—multiple sclerosis	6.96e-05	0.00321	CcSEcCtD
Methyltestosterone—CYP2B6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	6.94e-05	0.00945	CbGpPWpGaD
Methyltestosterone—CYP2B6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	6.94e-05	0.00945	CbGpPWpGaD
Methyltestosterone—Anaphylactic shock—Betamethasone—multiple sclerosis	6.79e-05	0.00313	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Dexamethasone—multiple sclerosis	6.79e-05	0.00313	CcSEcCtD
Methyltestosterone—Paraesthesia—Triamcinolone—multiple sclerosis	6.72e-05	0.0031	CcSEcCtD
Methyltestosterone—Paraesthesia—Methylprednisolone—multiple sclerosis	6.71e-05	0.00309	CcSEcCtD
Methyltestosterone—CYP19A1—Endogenous sterols—POMC—multiple sclerosis	6.46e-05	0.0088	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	6.44e-05	0.00878	CbGpPWpGaD
Methyltestosterone—Angiopathy—Methotrexate—multiple sclerosis	6.32e-05	0.00291	CcSEcCtD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	6.29e-05	0.00858	CbGpPWpGaD
Methyltestosterone—Headache—Mitoxantrone—multiple sclerosis	6.22e-05	0.00287	CcSEcCtD
Methyltestosterone—Anxiety—Prednisone—multiple sclerosis	6.15e-05	0.00284	CcSEcCtD
Methyltestosterone—Alopecia—Methotrexate—multiple sclerosis	6.15e-05	0.00284	CcSEcCtD
Methyltestosterone—AR—SIDS Susceptibility Pathways—C4A—multiple sclerosis	6.13e-05	0.00836	CbGpPWpGaD
Methyltestosterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	6.13e-05	0.00835	CbGpPWpGaD
Methyltestosterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	6.13e-05	0.00835	CbGpPWpGaD
Methyltestosterone—Paraesthesia—Dexamethasone—multiple sclerosis	6.1e-05	0.00281	CcSEcCtD
Methyltestosterone—Paraesthesia—Betamethasone—multiple sclerosis	6.1e-05	0.00281	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Prednisone—multiple sclerosis	5.92e-05	0.00273	CcSEcCtD
Methyltestosterone—Nausea—Mitoxantrone—multiple sclerosis	5.9e-05	0.00272	CcSEcCtD
Methyltestosterone—AR—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	5.77e-05	0.00786	CbGpPWpGaD
Methyltestosterone—CYP19A1—Biological oxidations—CYP24A1—multiple sclerosis	5.74e-05	0.00782	CbGpPWpGaD
Methyltestosterone—CYP19A1—Biological oxidations—CYP27B1—multiple sclerosis	5.74e-05	0.00782	CbGpPWpGaD
Methyltestosterone—ALB—HDL-mediated lipid transport—APOE—multiple sclerosis	5.72e-05	0.00779	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	5.66e-05	0.00771	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	5.66e-05	0.00771	CbGpPWpGaD
Methyltestosterone—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	5.53e-05	0.00753	CbGpPWpGaD
Methyltestosterone—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	5.42e-05	0.00739	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	5.42e-05	0.00738	CbGpPWpGaD
Methyltestosterone—Paraesthesia—Prednisone—multiple sclerosis	5.31e-05	0.00245	CcSEcCtD
Methyltestosterone—Headache—Prednisolone—multiple sclerosis	5.1e-05	0.00235	CcSEcCtD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	5.02e-05	0.00684	CbGpPWpGaD
Methyltestosterone—Anaphylactic shock—Methotrexate—multiple sclerosis	4.95e-05	0.00228	CcSEcCtD
Methyltestosterone—SLCO1A2—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	4.91e-05	0.00669	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	4.84e-05	0.00659	CbGpPWpGaD
Methyltestosterone—Nausea—Prednisolone—multiple sclerosis	4.84e-05	0.00223	CcSEcCtD
Methyltestosterone—Progesterone—PGR—multiple sclerosis	4.82e-05	0.0295	CrCbGaD
Methyltestosterone—AR—Generic Transcription Pathway—ZNF746—multiple sclerosis	4.73e-05	0.00644	CbGpPWpGaD
Methyltestosterone—Headache—Triamcinolone—multiple sclerosis	4.69e-05	0.00216	CcSEcCtD
Methyltestosterone—Headache—Methylprednisolone—multiple sclerosis	4.68e-05	0.00216	CcSEcCtD
Methyltestosterone—ALB—Platelet degranulation—PLEK—multiple sclerosis	4.67e-05	0.00636	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	4.65e-05	0.00633	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	4.65e-05	0.00633	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Bile acid and bile salt metabolism—ALB—multiple sclerosis	4.55e-05	0.0062	CbGpPWpGaD
Methyltestosterone—Nausea—Triamcinolone—multiple sclerosis	4.45e-05	0.00205	CcSEcCtD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	4.45e-05	0.00606	CbGpPWpGaD
Methyltestosterone—Paraesthesia—Methotrexate—multiple sclerosis	4.44e-05	0.00205	CcSEcCtD
Methyltestosterone—Nausea—Methylprednisolone—multiple sclerosis	4.44e-05	0.00205	CcSEcCtD
Methyltestosterone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	4.41e-05	0.00601	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	4.36e-05	0.00594	CbGpPWpGaD
Methyltestosterone—Headache—Betamethasone—multiple sclerosis	4.26e-05	0.00196	CcSEcCtD
Methyltestosterone—Headache—Dexamethasone—multiple sclerosis	4.26e-05	0.00196	CcSEcCtD
Methyltestosterone—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	4.19e-05	0.00571	CbGpPWpGaD
Methyltestosterone—Nausea—Dexamethasone—multiple sclerosis	4.04e-05	0.00186	CcSEcCtD
Methyltestosterone—Nausea—Betamethasone—multiple sclerosis	4.04e-05	0.00186	CcSEcCtD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	3.99e-05	0.00543	CbGpPWpGaD
Methyltestosterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	3.89e-05	0.0053	CbGpPWpGaD
Methyltestosterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	3.89e-05	0.0053	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	3.88e-05	0.00528	CbGpPWpGaD
Methyltestosterone—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	3.84e-05	0.00523	CbGpPWpGaD
Methyltestosterone—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	3.84e-05	0.00523	CbGpPWpGaD
Methyltestosterone—SLCO1A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	3.72e-05	0.00507	CbGpPWpGaD
Methyltestosterone—Headache—Prednisone—multiple sclerosis	3.71e-05	0.00171	CcSEcCtD
Methyltestosterone—CYP2B6—Biological oxidations—CYP27B1—multiple sclerosis	3.69e-05	0.00502	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	3.69e-05	0.00502	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	3.64e-05	0.00495	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	3.64e-05	0.00495	CbGpPWpGaD
Methyltestosterone—Nausea—Prednisone—multiple sclerosis	3.51e-05	0.00162	CcSEcCtD
Methyltestosterone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	3.49e-05	0.00476	CbGpPWpGaD
Methyltestosterone—AR—Notch-mediated HES/HEY network—CD4—multiple sclerosis	3.4e-05	0.00464	CbGpPWpGaD
Methyltestosterone—AR—Nongenotropic Androgen signaling—MAPK1—multiple sclerosis	3.34e-05	0.00455	CbGpPWpGaD
Methyltestosterone—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	3.29e-05	0.00448	CbGpPWpGaD
Methyltestosterone—CYP19A1—FSH signaling pathway—MAPK1—multiple sclerosis	3.21e-05	0.00438	CbGpPWpGaD
Methyltestosterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	3.15e-05	0.0043	CbGpPWpGaD
Methyltestosterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	3.15e-05	0.0043	CbGpPWpGaD
Methyltestosterone—Headache—Methotrexate—multiple sclerosis	3.1e-05	0.00143	CcSEcCtD
Methyltestosterone—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3e-05	0.00409	CbGpPWpGaD
Methyltestosterone—Nausea—Methotrexate—multiple sclerosis	2.94e-05	0.00135	CcSEcCtD
Methyltestosterone—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2.93e-05	0.00399	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.81e-05	0.00383	CbGpPWpGaD
Methyltestosterone—AR—Notch-mediated HES/HEY network—STAT3—multiple sclerosis	2.64e-05	0.00359	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	2.62e-05	0.00357	CbGpPWpGaD
Methyltestosterone—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2.6e-05	0.00354	CbGpPWpGaD
Methyltestosterone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	2.56e-05	0.00349	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.55e-05	0.00347	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.49e-05	0.0034	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.44e-05	0.00332	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.44e-05	0.00332	CbGpPWpGaD
Methyltestosterone—CYP19A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.43e-05	0.00331	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	2.4e-05	0.00328	CbGpPWpGaD
Methyltestosterone—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	2.4e-05	0.00327	CbGpPWpGaD
Methyltestosterone—Prednisone—ALB—multiple sclerosis	2.36e-05	0.0145	CrCbGaD
Methyltestosterone—Norethindrone—ALB—multiple sclerosis	2.32e-05	0.0142	CrCbGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—IL10—multiple sclerosis	2.3e-05	0.00313	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—ZNF746—multiple sclerosis	2.28e-05	0.0031	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.2e-05	0.003	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.2e-05	0.003	CbGpPWpGaD
Methyltestosterone—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	2.18e-05	0.00297	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	2.15e-05	0.00293	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.13e-05	0.0029	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—PTBP1—multiple sclerosis	2.08e-05	0.00284	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	2.07e-05	0.00282	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—IL4—multiple sclerosis	2.07e-05	0.00282	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.05e-05	0.00279	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	2.02e-05	0.00275	CbGpPWpGaD
Methyltestosterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	2e-05	0.00273	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—multiple sclerosis	1.94e-05	0.00264	CbGpPWpGaD
Methyltestosterone—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.93e-05	0.00262	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.89e-05	0.00258	CbGpPWpGaD
Methyltestosterone—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	1.82e-05	0.00248	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	1.81e-05	0.00246	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.75e-05	0.00238	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—CD58—multiple sclerosis	1.73e-05	0.00235	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—SELPLG—multiple sclerosis	1.73e-05	0.00235	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—MERTK—multiple sclerosis	1.73e-05	0.00235	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.68e-05	0.00229	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	1.68e-05	0.00228	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	1.68e-05	0.00228	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.65e-05	0.00225	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.65e-05	0.00225	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—ICAM1—multiple sclerosis	1.64e-05	0.00224	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—multiple sclerosis	1.6e-05	0.00218	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	1.58e-05	0.00216	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—STAT3—multiple sclerosis	1.58e-05	0.00215	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—U2AF2—multiple sclerosis	1.58e-05	0.00215	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—HNRNPA1—multiple sclerosis	1.58e-05	0.00215	CbGpPWpGaD
Methyltestosterone—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.56e-05	0.00213	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—SRM—multiple sclerosis	1.54e-05	0.0021	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	1.54e-05	0.00209	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.49e-05	0.00204	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.49e-05	0.00203	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—CCL2—multiple sclerosis	1.47e-05	0.002	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—PGR—multiple sclerosis	1.43e-05	0.00194	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—SRM—multiple sclerosis	1.39e-05	0.0019	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	1.37e-05	0.00187	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.32e-05	0.0018	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	1.3e-05	0.00178	CbGpPWpGaD
Methyltestosterone—CYP19A1—Biological oxidations—POMC—multiple sclerosis	1.29e-05	0.00176	CbGpPWpGaD
Methyltestosterone—Testosterone—ALB—multiple sclerosis	1.28e-05	0.00785	CrCbGaD
Methyltestosterone—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	1.27e-05	0.00173	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—IFNG—multiple sclerosis	1.25e-05	0.0017	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—ZFP36L1—multiple sclerosis	1.25e-05	0.0017	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.22e-05	0.00166	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.2e-05	0.00164	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.19e-05	0.00162	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.19e-05	0.00162	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	1.17e-05	0.00159	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—IL1B—multiple sclerosis	1.11e-05	0.00152	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—IL2—multiple sclerosis	1.11e-05	0.00151	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CYP24A1—multiple sclerosis	1.09e-05	0.00148	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CYP27B1—multiple sclerosis	1.09e-05	0.00148	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PLEK—multiple sclerosis	1.07e-05	0.00145	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.06e-05	0.00145	CbGpPWpGaD
Methyltestosterone—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.05e-05	0.00144	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—VDR—multiple sclerosis	9.97e-06	0.00136	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	9.94e-06	0.00135	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GPC5—multiple sclerosis	9.93e-06	0.00135	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	9.93e-06	0.00135	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	9.82e-06	0.00134	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	9.82e-06	0.00134	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—PABPC1—multiple sclerosis	9.67e-06	0.00132	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	9.63e-06	0.00131	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.59e-06	0.00131	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	9.42e-06	0.00128	CbGpPWpGaD
Methyltestosterone—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	9.36e-06	0.00128	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.24e-06	0.00126	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GPC5—multiple sclerosis	8.98e-06	0.00122	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—SRM—multiple sclerosis	8.95e-06	0.00122	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	8.85e-06	0.00121	CbGpPWpGaD
Methyltestosterone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.75e-06	0.00119	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—TNF—multiple sclerosis	8.74e-06	0.00119	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—RPL5—multiple sclerosis	8.73e-06	0.00119	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—POMC—multiple sclerosis	8.29e-06	0.00113	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	8.28e-06	0.00113	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—RRM1—multiple sclerosis	8.23e-06	0.00112	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	8.1e-06	0.0011	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TNF—multiple sclerosis	8.09e-06	0.0011	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	8.02e-06	0.00109	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	7.98e-06	0.00109	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	7.96e-06	0.00108	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	7.8e-06	0.00106	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SRM—multiple sclerosis	7.53e-06	0.00103	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—SELE—multiple sclerosis	7.52e-06	0.00102	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—RRM1—multiple sclerosis	7.44e-06	0.00101	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	7.43e-06	0.00101	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—TGFB1—multiple sclerosis	7.43e-06	0.00101	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.3e-06	0.000995	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	7.2e-06	0.000981	CbGpPWpGaD
Methyltestosterone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.09e-06	0.000966	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	7.07e-06	0.000964	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—IL6—multiple sclerosis	7.05e-06	0.000961	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—PGR—multiple sclerosis	6.87e-06	0.000936	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—IL6—multiple sclerosis	6.53e-06	0.000889	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.45e-06	0.000879	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	6.43e-06	0.000875	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.39e-06	0.00087	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	6.3e-06	0.000859	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	6.3e-06	0.000859	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.77e-06	0.000786	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GPC5—multiple sclerosis	5.77e-06	0.000786	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.49e-06	0.000747	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—ITGA4—multiple sclerosis	5.44e-06	0.00074	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IFNB1—multiple sclerosis	5.4e-06	0.000735	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.36e-06	0.00073	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP24A1—multiple sclerosis	5.31e-06	0.000723	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP27B1—multiple sclerosis	5.31e-06	0.000723	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.19e-06	0.000707	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	5.19e-06	0.000706	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5e-06	0.000681	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.96e-06	0.000676	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GPC5—multiple sclerosis	4.85e-06	0.000661	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—VDR—multiple sclerosis	4.8e-06	0.000654	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—RRM1—multiple sclerosis	4.78e-06	0.000651	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.76e-06	0.000648	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—BCHE—multiple sclerosis	4.73e-06	0.000644	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.52e-06	0.000616	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—BCHE—multiple sclerosis	4.27e-06	0.000582	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	4.22e-06	0.000575	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SRM—multiple sclerosis	4.07e-06	0.000554	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—RRM1—multiple sclerosis	4.02e-06	0.000548	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—MYC—multiple sclerosis	3.96e-06	0.00054	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.77e-06	0.000513	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IL2RA—multiple sclerosis	3.71e-06	0.000506	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	3.29e-06	0.000449	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	3.23e-06	0.00044	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.12e-06	0.000425	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.86e-06	0.00039	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.86e-06	0.00039	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—APOE—multiple sclerosis	2.84e-06	0.000387	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.74e-06	0.000374	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.68e-06	0.000365	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.62e-06	0.000357	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—APOE—multiple sclerosis	2.57e-06	0.00035	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—POMC—multiple sclerosis	2.44e-06	0.000333	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—BCHE—multiple sclerosis	2.31e-06	0.000315	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ALB—multiple sclerosis	2.23e-06	0.000303	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—POMC—multiple sclerosis	2.21e-06	0.000301	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IL2—multiple sclerosis	2.18e-06	0.000297	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.17e-06	0.000296	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ALB—multiple sclerosis	2.01e-06	0.000274	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—MYC—multiple sclerosis	1.91e-06	0.00026	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TGFB1—multiple sclerosis	1.7e-06	0.000231	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—MAPK1—multiple sclerosis	1.67e-06	0.000227	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—APOE—multiple sclerosis	1.65e-06	0.000225	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—POMC—multiple sclerosis	1.42e-06	0.000193	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—APOE—multiple sclerosis	1.39e-06	0.000189	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ALB—multiple sclerosis	1.29e-06	0.000176	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.25e-06	0.00017	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—POMC—multiple sclerosis	1.19e-06	0.000163	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—APOE—multiple sclerosis	7.5e-07	0.000102	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—POMC—multiple sclerosis	6.44e-07	8.78e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ALB—multiple sclerosis	5.88e-07	8e-05	CbGpPWpGaD
